{"id":27934,"date":"2020-03-15T11:51:17","date_gmt":"2020-03-15T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=27934"},"modified":"2020-03-15T11:51:17","modified_gmt":"2020-03-15T17:51:17","slug":"animal-health-news-and-notes-for-march-13-2020","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-and-notes-for-march-13-2020\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 13 de mar\u00e7o de 2020"},"content":{"rendered":"<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <\/strong><br \/>\n<strong>Not\u00edcias e notas de sa\u00fade animal de 13 de mar\u00e7o<\/strong><strong>, 2020<\/strong><br \/>\n<em>Copyright \u00a9 Brakke Consulting<br \/>\n<\/em><em>Editor: Lynn Fondon DVM MBA<br \/>\n<\/em>************************************<\/p>\n<p>NAS NOTICIAS:<\/p>\n<p><u>not\u00edcias de ganhos<br \/>\n<\/u>ceva<br \/>\nPetIQ<\/p>\n<p><u>outras not\u00edcias<br \/>\n<\/u>Airvet<br \/>\nCadila Sa\u00fade<br \/>\nCannPal Animal Therapeutics<br \/>\nCerrado Nutri\u00e7\u00e3o Animal<br \/>\nHempvet<br \/>\nImmuCellName<br \/>\nInd\u00fastrias Kemin<br \/>\nKVP Internacional<br \/>\nTecnologia MYOS RENS<br \/>\nNeogen<br \/>\nPebble Labs EUA<br \/>\nRoyal De Heus<br \/>\nGrupos de Estudos Veterin\u00e1rios<br \/>\nVirbac SA<br \/>\nSa\u00fade Animal Zydus<strong><br \/>\n<\/strong><\/p>\n<p><strong>************************************<\/strong><\/p>\n<p><strong>RELEASES DE RESULTADOS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Grupo Ceva r<\/strong>reportou resultados para todo o ano de 2019. As vendas consolidadas atingiram mais de EUR 1,2 bilh\u00e3o ($1,4 bilh\u00e3o), um aumento de 14,6% em rela\u00e7\u00e3o a 2018 (+10,4% CER). O grupo registou crescimentos positivos em todas as zonas geogr\u00e1ficas. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>PetIQ<\/strong>, Inc. relatou resultados financeiros para o ano encerrado em 31 de dezembro de 2019. As vendas l\u00edquidas foram de $709 milh\u00f5es, um aumento de 34% ano a ano; excluindo a contribui\u00e7\u00e3o da Perrigo Animal Health, as vendas l\u00edquidas aumentaram 29%. As vendas l\u00edquidas do segmento de produtos aumentaram 37% para $617 milh\u00f5es; A receita l\u00edquida do segmento de servi\u00e7os aumentou 22% para $19,4 milh\u00f5es. O preju\u00edzo l\u00edquido foi de $(14,3) milh\u00f5es, em compara\u00e7\u00e3o com o lucro l\u00edquido de $0,1 milh\u00f5es em 2018. O preju\u00edzo l\u00edquido de 2019 incluiu despesas incrementais de $34,9 milh\u00f5es atribu\u00edveis a $28,5 milh\u00f5es de despesas de aquisi\u00e7\u00e3o n\u00e3o recorrentes e $6,4 milh\u00f5es de juros incrementais relacionados ao financiamento da aquisi\u00e7\u00e3o da Perrigo Animal Health que foi conclu\u00edda em julho de 2019.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<\/ul>\n<p><strong>***********************************<\/strong><br \/>\n<strong>Alian\u00e7a de Agricultura Animal<br \/>\n<\/strong><strong>Encontro de Partes Interessadas 2020<br \/>\n<\/strong><strong>7 a 8 de maio | Arlington, Virg\u00ednia<\/strong><strong><br \/>\n<\/strong><\/p>\n<p>Participe do 2020 Stakeholders Summit e voc\u00ea estar\u00e1 preparado para construir pontes da fazenda \u00e0 mesa.<\/p>\n<p>Todos n\u00f3s temos interesse no futuro da pecu\u00e1ria \u2013 de fazendeiros e pecuaristas a veterin\u00e1rios e zootecnistas, executivos de restaurantes, varejo e servi\u00e7os de alimenta\u00e7\u00e3o e todos os elos da cadeia alimentar intermedi\u00e1rios. A C\u00fapula de Partes Interessadas de 2020 da Animal Agriculture Alliance proporcionar\u00e1 uma oportunidade de se reunir, aprender uns com os outros e desenvolver as ferramentas adequadas para se envolver em conversas sobre quest\u00f5es importantes e garantir nossos meios de subsist\u00eancia. As sess\u00f5es abordar\u00e3o sustentabilidade, bem-estar animal, engajamento de influenciadores, prepara\u00e7\u00e3o para campanhas de ativistas pelos direitos dos animais e outros t\u00f3picos importantes.<\/p>\n<p>Para mais detalhes e para se inscrever, clique <a href=\"http:\/\/trk.cp20.com\/click\/g9hw-t01-5ch3-ex3kd5\/\">aqui.<\/a> Os descontos para inscri\u00e7\u00f5es antecipadas est\u00e3o dispon\u00edveis at\u00e9 3 de abril.<\/p>\n<p><strong>************************************<\/strong><\/p>\n<p><strong>COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Virbac SA <\/strong>e <strong>Pebble Labs EUA<\/strong> anunciou que as empresas firmaram acordos para co-desenvolver e comercializar solu\u00e7\u00f5es inovadoras para a preven\u00e7\u00e3o de doen\u00e7as na aquicultura. A tecnologia Pebble Labs Directed Biotics aproveita a imunidade natural do camar\u00e3o com uma bact\u00e9ria e a redireciona para suprimir o v\u00edrus da s\u00edndrome da mancha branca. <em>(News.yahoo.com)<\/em><\/li>\n<li><strong>Corpora\u00e7\u00e3o Neogen<\/strong> anunciou que est\u00e1 aumentando seu estoque de desinfetantes para as m\u00e3os, toalhetes desinfetantes, luvas de nitrilo e desinfetantes para ajudar no esfor\u00e7o global para retardar a propaga\u00e7\u00e3o do coronav\u00edrus. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>ImmuCellName<\/strong> anunciou um refinanciamento completo de sua d\u00edvida banc\u00e1ria. A Companhia fechou em $8,6 milh\u00f5es de d\u00edvida, composta por tr\u00eas componentes. O primeiro componente \u00e9 uma nota de hipoteca de $5,1 milh\u00f5es de dez anos; o segundo componente \u00e9 uma nota de $3,5 milh\u00f5es de sete anos; o terceiro componente \u00e9 uma linha de cr\u00e9dito de $1 milh\u00f5es. A Companhia tinha anteriormente cinco empr\u00e9stimos diferentes que haviam sido contra\u00eddos durante diferentes est\u00e1gios de seus programas de investimento de capital.<em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Ind\u00fastrias Kemin<\/strong> anunciou o lan\u00e7amento de Kessent \u2013 uma linha de produtos de metionina protegida no r\u00famen \u2013 e CholiGEM \u2013 um suplemento nutricional de colina encapsulada \u2013 na Europa, Oriente M\u00e9dio e Norte da \u00c1frica. <em>(Farm\u00e1cia Animal)<\/em><\/li>\n<li><strong>Tecnologia MYOS RENS <\/strong> anunciou que firmou um acordo de co-marketing e distribui\u00e7\u00e3o com <strong>KVP Internacional<\/strong>, Inc., fornecedora de produtos inovadores para o mercado de reabilita\u00e7\u00e3o veterin\u00e1ria.<em> (Yahoo finan\u00e7as)<\/em><\/li>\n<li><strong>Airvet<\/strong> anunciou uma parceria para ser a plataforma de telemedicina preferida dos mais de 1.400 consult\u00f3rios membros da <strong>Grupos de Estudos Veterin\u00e1rios<\/strong><em> (JAVMA)<\/em><\/li>\n<li><strong>Hempvet<\/strong> anunciou o lan\u00e7amento de nove novos produtos de canabidiol (CBD) para animais de estima\u00e7\u00e3o, incluindo o primeiro para gatos e cavalos. Cada um de seus nove novos produtos \u00e9 projetado para tratar de quest\u00f5es espec\u00edficas.<em> (Farm\u00e1cia Animal)<\/em><\/li>\n<li><strong>CannPal Animal Therapeutics <\/strong>anunciou que o Centro de Medicina Veterin\u00e1ria (CVM) da FDA estabeleceu um arquivo de nova droga animal experimental (INAD) para CPAT-01, um produto farmac\u00eautico altamente purificado derivado de extratos naturais de tetra-hidrocanabinol e canabidiol. A CannPal est\u00e1 desenvolvendo o CPAT-01 como um medicamento veterin\u00e1rio para a redu\u00e7\u00e3o dos sintomas associados \u00e0 osteoartrite. <em>(Farm\u00e1cia Animal<\/em><\/li>\n<li>BRASIL <strong>Royal De Heus<\/strong> anunciou que adquiriu <strong>Cerrado Nutri\u00e7\u00e3o Animal<\/strong>, que produz uma gama de produtos l\u00e1cteos e de nutri\u00e7\u00e3o bovina para o mercado bovino brasileiro. Os termos financeiros n\u00e3o foram divulgados.<em> (Farm\u00e1cia Animal)<\/em><\/li>\n<li>\u00cdNDIA <strong>Cadila Sa\u00fade<\/strong> Ltd anunciou que est\u00e1 transferindo o Neg\u00f3cio de Sa\u00fade Animal (AHB) da Companhia, em continuidade operacional, para sua subsidi\u00e1ria integral <strong>Zydus Animal Health and Investments Limited<\/strong>. Nenhuma contrapresta\u00e7\u00e3o em dinheiro ser\u00e1 paga pela ZAHL pela transfer\u00eancia da AHB. A ZAHL emitir\u00e1 e distribuir\u00e1 a\u00e7\u00f5es agregando a Rs. 2.273,35 crores ($32 milh\u00f5es) em troca da transfer\u00eancia de AHB. O faturamento da AHB no ano encerrado em 31 de mar\u00e7o de 2019 foi de Rs. 510,90 crores ($7 milh\u00f5es). <em>(Equitybulls.com)<\/em><\/li>\n<\/ul>\n<p>***********************************<\/p>\n<p><strong>RASTREADOR DE PRE\u00c7O DE A\u00c7\u00d5ES DE SA\u00daDE ANIMAL<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-27935\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg\" alt=\"\" width=\"977\" height=\"639\" srcset=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg 977w, https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13-480x314.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 977px, 100vw\" \/><\/p>\n<p>***********************************<\/p>\n<p><strong>NOT\u00cdCIAS DE SA\u00daDE ANIMAL<\/strong><\/p>\n<ul>\n<li>EUA \u2013 PREPARA\u00c7\u00c3O PARA A PSA O USDA anunciou um plano de a\u00e7\u00e3o contra a peste su\u00edna africana (PSA) caso a doen\u00e7a exclusivamente su\u00edna seja detectada nos EUA. O secret\u00e1rio da agricultura tomaria imediatamente as medidas necess\u00e1rias para declarar uma \u201cemerg\u00eancia extraordin\u00e1ria\u201d estabelecendo o USDA como l\u00edder de uma abordagem nacional coordenada para controle e erradica\u00e7\u00e3o e emitiria uma paralisa\u00e7\u00e3o nacional de pelo menos 72 horas para proibir todo movimento de su\u00ednos. Para mais detalhes clique <a href=\"https:\/\/www.feedstuffs.com\/news\/usda-announces-asf-response-plan?NL=FP-018&amp;Issue=FP-018_20200306_FP-018_135&amp;cl=article_1_b&amp;utm_rid=CPG02000000634415&amp;utm_campaign=47277&amp;utm_medium=email&amp;elq2=0ba4b138f56d46b4a44dbd88901f13ef\">aqui<\/a>.<em>(alimentos)<\/em><\/li>\n<li>EUA \u2013 INSPE\u00c7\u00d5ES DE ALIMENTOS A FDA anunciou que, ap\u00f3s o coronav\u00edrus, est\u00e1 adiando a maioria das inspe\u00e7\u00f5es de alimentos estrangeiros at\u00e9 abril, com efeito imediato. Nesse \u00ednterim, a FDA planeja empregar ferramentas adicionais para garantir a seguran\u00e7a dos produtos importados para os EUA. Isso inclui negar a entrada de produtos inseguros nos EUA, exames f\u00edsicos e\/ou amostragem de produtos nas fronteiras dos EUA, revisar o hist\u00f3rico anterior de conformidade de uma empresa, usar o compartilhamento de informa\u00e7\u00f5es de governos estrangeiros como parte de acordos de reconhecimento m\u00fatuo e confidencialidade e solicitar registros \u201cantes de ou em vez de\u201d inspe\u00e7\u00f5es de drogas no local. <em>(alimentos)<\/em><\/li>\n<li>MUNDO \u2013 MEDICAMENTOS PARA PEQUENOS ANIMAIS A Associa\u00e7\u00e3o Mundial de Veterin\u00e1rios para Pequenos Animais (WSAVA) lan\u00e7ou uma Lista de Medicamentos Essenciais para C\u00e3es e Gatos. Desenvolvido pelo Grupo de Diretrizes Terap\u00eauticas (TGG) da associa\u00e7\u00e3o, o documento visa solucionar as dificuldades que existem para os veterin\u00e1rios de animais de companhia em muitas regi\u00f5es do mundo no acesso a medicamentos veterin\u00e1rios vitais, apoiando a disponibilidade dos medicamentos necess\u00e1rios para os padr\u00f5es m\u00ednimos da pr\u00e1tica cl\u00ednica. Para ver a lista, clique <a href=\"https:\/\/wsava.org\/wp-content\/uploads\/2020\/03\/WSAVA_List_of_Essential_Medicines_for_Cats_and_Dogs_final.pdf\">aqui.<\/a><em>\u00a0(comunicado de imprensa da associa\u00e7\u00e3o)<\/em><\/li>\n<\/ul>\n<p>************************************<br \/>\n<strong>PONTO DE VISTA DA BRAKKE CONSULTORIA<\/strong><\/p>\n<p>Onde quer que voc\u00ea vire e em todos os meios de comunica\u00e7\u00e3o, o COVID-19 agora \u00e9 a hist\u00f3ria principal. Nesta semana, v\u00e1rias universidades est\u00e3o suspendendo as aulas presenciais e mudando para aulas virtuais no curto prazo ou, em alguns casos, at\u00e9 o final do semestre. Conven\u00e7\u00f5es e confer\u00eancias est\u00e3o sendo canceladas ou remarcadas. A maioria dos esportes profissionais, NBA, NHL e MLB suspenderam o jogo. E o March Madness n\u00e3o ter\u00e1 muita loucura com locais sem f\u00e3s.<\/p>\n<p>Ouvimos dizer que algumas empresas de sa\u00fade animal est\u00e3o cancelando reuni\u00f5es e tamb\u00e9m restringindo viagens al\u00e9m das restri\u00e7\u00f5es anunciadas esta semana para viagens da Europa. O impacto econ\u00f4mico do COVID-19 ser\u00e1 de longo alcance quando tudo estiver dito e feito.<\/p>\n<p>\u00c9 muito cedo para saber se o tr\u00e1fego de pedestres nas cl\u00ednicas veterin\u00e1rias foi afetado, mas essa \u00e9 uma possibilidade distinta. Assim como o governo federal anunciou que o Medicare cobrir\u00e1 visitas de telemedicina, isso pode ser apenas o \u00edmpeto para impulsionar a expans\u00e3o da telemedicina na ind\u00fastria veterin\u00e1ria. Al\u00e9m disso, as cl\u00ednicas veterin\u00e1rias que oferecem op\u00e7\u00f5es de entrega em domic\u00edlio a seus pacientes para rem\u00e9dios para animais de estima\u00e7\u00e3o podem estar melhor posicionadas para fornecer uma continuidade de atendimento mais forte a seus clientes do que aquelas que n\u00e3o o fazem e podem perder clientes para os varejistas on-line com farm\u00e1cias de prescri\u00e7\u00e3o.<\/p>\n<p>Estamos prontos para funcionar como uma sociedade virtual? Algumas das respostas tempor\u00e1rias ao COVID-19 pelas empresas se tornar\u00e3o permanentes? Isso nos tornar\u00e1 melhores? Estamos atentos \u00e0s mudan\u00e7as... mas agora vou lavar as m\u00e3os.<\/p>\n<p><em>\u00a0Randy Freides<\/em><\/p>\n<p>***********************************<br \/>\n<strong>SUA VIS\u00c3O<\/p>\n<p><\/strong>Na semana passada, perguntamos sobre as mudan\u00e7as na cadeia de suprimentos no setor de sa\u00fade animal devido ao COVID-19. No geral, as respostas foram divididas igualmente entre \u201csim\u201d e \u201cn\u00e3o\u201d. Sobre 18% disse: \u201cSim \u2013 haver\u00e1 mudan\u00e7as de mudan\u00e7a de paradigma\u201d e 27% disse: \u201cSim \u2013 mas elas ser\u00e3o menores. Da mesma forma, 27% disse: \u201cN\u00e3o \u2013 este \u00e9 apenas um problema tempor\u00e1rio da cadeia de suprimentos\u201d e 23% disse: \u201cN\u00e3o \u2013 registrar uma nova fabrica\u00e7\u00e3o fora da China \u00e9 muito caro e leva muito tempo\u201d. E 5% dos entrevistados n\u00e3o tinham certeza.<\/p>\n<p>Permanecendo com o COVID-19, aqui fica a pergunta da semana:<\/p>\n<p><a href=\"https:\/\/www.surveymonkey.com\/r\/NBHJHHG\"><strong>A sua empresa ou neg\u00f3cio tem um plano de conting\u00eancia laboral devido ao COVID-19?<\/strong><\/a><\/p>\n<p>**********************************<\/p>\n<p>Problemas para visualizar esta newsletter? Voc\u00ea pode visualiz\u00e1-lo online em <a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a><\/p>\n<p><em>Este boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting.<\/em><\/p>\n<p>Para obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<\/p>\n<p>Brakke Consultoria<br \/>\nRua Green Valley, 806<br \/>\nSu\u00edte 200<br \/>\nGreensboro, NC 27408<\/p>","protected":false},"excerpt":{"rendered":"<p>*********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 13 de mar\u00e7o de 2020 Copyright \u00a9 Brakke Editora Consultora: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: not\u00edcias sobre ganhos Ceva PetIQ outras novidades Airvet Cadila Healthcare CannPal Animal Therapeutics Cerrado Nutri\u00e7\u00e3o Animal Hempvet ImmuCell Kemin Industries KVP Internacional MYOS RENS Tecnologia Neogen Pebble Labs EUA Royal De Heus Veterinary Study Groups Virbac SA Zydus Animal Health ************** ********************** DIVULGA\u00c7\u00d5ES DE GANHOS DA EMPRESA O Grupo Ceva reportou resultados para todo o ano de 2019. As vendas consolidadas atingiram mais de 1,2 bilh\u00e3o de euros ($1,4 bilh\u00e3o), um aumento de 14,6% em rela\u00e7\u00e3o a 2018 (+10,4% CER). O grupo registou um crescimento positivo em todas as zonas geogr\u00e1ficas. (comunicado \u00e0 imprensa da empresa) PetIQ, Inc. relatou resultados financeiros para o ano completo encerrado em 31 de dezembro de 2019. As vendas l\u00edquidas foram de $709 milh\u00f5es, um aumento de 34% ano a ano; excluindo a contribui\u00e7\u00e3o da Perrigo Animal Health, as vendas l\u00edquidas aumentaram 29%. As vendas l\u00edquidas do segmento de produtos aumentaram 37% para $617 milh\u00f5es; A receita l\u00edquida do segmento de servi\u00e7os aumentou 22% para $19,4 milh\u00f5es. O preju\u00edzo l\u00edquido foi de $ (14,3) milh\u00f5es, em compara\u00e7\u00e3o com o lucro l\u00edquido de $0,1 milh\u00f5es em 2018. O preju\u00edzo l\u00edquido de 2019 incluiu $34,9 milh\u00f5es de despesas incrementais atribu\u00edveis a $28,5 milh\u00f5es de despesas de aquisi\u00e7\u00e3o n\u00e3o recorrentes e $6,4 milh\u00f5es de juros incrementais relativos ao financiamento da aquisi\u00e7\u00e3o da Perrigo Animal Health conclu\u00edda em julho de 2019. (comunicado \u00e0 imprensa da empresa) *************************** ******** C\u00fapula das Partes Interessadas da Animal Agriculture Alliance 2020<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-and-notes-for-march-13-2020\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-27934","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-and-notes-for-march-13-2020\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for March 13, 2020 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: earnings news Ceva PetIQ other news Airvet Cadila Healthcare CannPal Animal Therapeutics Cerrado Nutri\u00e7\u00e3o Animal Hempvet ImmuCell Kemin Industries KVP International MYOS RENS Technology Neogen Pebble Labs USA Royal De Heus Veterinary Study Groups Virbac SA Zydus Animal Health ************************************ COMPANY EARNINGS RELEASES Ceva Group reported results for the full year 2019. Consolidated sales reached more than EUR 1.2 billion ($1.4 billion), an increase of 14.6% over 2018 (+10.4% CER). The group recorded positive growth in all geographical zones. (company press release) PetIQ, Inc. reported financial results for the full year ended December 31, 2019. Net sales were $709 million, an increase of 34% year-over-year; excluding contribution from Perrigo Animal Health, net sales increased 29%. Product segment net sales increased 37% to $617 million; Services segment net revenues increased 22% to $19.4 million. Net loss was $(14.3) million, compared to net income of $0.1 million in 2018. The 2019 net loss included $34.9 million incremental expense attributable to $28.5 million of non-recurring acquisition expenses and $6.4 million of incremental interest relating to the financing of the Perrigo Animal Health acquisition that closed in July 2019. (company press release) *********************************** Animal Agriculture Alliance 2020 Stakeholders SummitView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-and-notes-for-march-13-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-15T17:51:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News and Notes for March 13, 2020\",\"datePublished\":\"2020-03-15T17:51:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/\"},\"wordCount\":1447,\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg\",\"datePublished\":\"2020-03-15T17:51:17+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#primaryimage\",\"url\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg\",\"contentUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News and Notes for March 13, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-and-notes-for-march-13-2020\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for March 13, 2020 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: earnings news Ceva PetIQ other news Airvet Cadila Healthcare CannPal Animal Therapeutics Cerrado Nutri\u00e7\u00e3o Animal Hempvet ImmuCell Kemin Industries KVP International MYOS RENS Technology Neogen Pebble Labs USA Royal De Heus Veterinary Study Groups Virbac SA Zydus Animal Health ************************************ COMPANY EARNINGS RELEASES Ceva Group reported results for the full year 2019. Consolidated sales reached more than EUR 1.2 billion ($1.4 billion), an increase of 14.6% over 2018 (+10.4% CER). The group recorded positive growth in all geographical zones. (company press release) PetIQ, Inc. reported financial results for the full year ended December 31, 2019. Net sales were $709 million, an increase of 34% year-over-year; excluding contribution from Perrigo Animal Health, net sales increased 29%. Product segment net sales increased 37% to $617 million; Services segment net revenues increased 22% to $19.4 million. Net loss was $(14.3) million, compared to net income of $0.1 million in 2018. The 2019 net loss included $34.9 million incremental expense attributable to $28.5 million of non-recurring acquisition expenses and $6.4 million of incremental interest relating to the financing of the Perrigo Animal Health acquisition that closed in July 2019. (company press release) *********************************** Animal Agriculture Alliance 2020 Stakeholders SummitView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-and-notes-for-march-13-2020\/","og_site_name":"Brakke Consulting Website","article_published_time":"2020-03-15T17:51:17+00:00","og_image":[{"url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg","type":"","width":"","height":""}],"author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News and Notes for March 13, 2020","datePublished":"2020-03-15T17:51:17+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/"},"wordCount":1447,"image":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg","articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/","url":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#primaryimage"},"image":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg","datePublished":"2020-03-15T17:51:17+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#primaryimage","url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg","contentUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/03\/Stock-Table-3.13.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-and-notes-for-march-13-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Animal Health News and Notes for March 13, 2020"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=27934"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27934\/revisions"}],"predecessor-version":[{"id":27936,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27934\/revisions\/27936"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=27934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=27934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=27934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}